Overview

Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer
Phase:
N/A
Details
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Treatments:
Cisplatin
Docetaxel
Doxorubicin
Liposomal doxorubicin